Crowdsourced campaign leads to blueprint for future pandemic drugs
New open-access format for drug discovery is accelerating global efforts to develop inexpensive generic medications against potential viral threats.
New open-access format for drug discovery is accelerating global efforts to develop inexpensive generic medications against potential viral threats.
Sheba Pandemic Research Institute to focus on multidisciplinary, collaborative infectious disease R&D of clinical products for emergency deployment.
Physicians counsel caution and innovative ways to educate the public and collect epidemiological data but do not expect a serious pandemic.
Report: Job openings at OurCrowd portfolio companies in Israel rose by 400% in six months, with software engineers most in demand.
Multidisciplinary center connects hospitals, government and academic institutions in Israel and around the world to prepare for future epidemics.
Lobel and a handful of other virologists around the world are stepping up research of arboviruses to try to understand why they may be getting more serious.